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Network analysisSystems approaches to analyzing disease phenotype networks in combination with protein functional
interaction networks have great potential in illuminating disease pathophysiological mechanisms. While
many genetic networks are readily available, disease phenotype networks remain largely incomplete. In
this study, we built a large-scale Disease Manifestation Network (DMN) from 50,543 highly accurate
disease-manifestation semantic relationships in the United Medical Language System (UMLS). Our new
phenotype network contains 2305 nodes and 373,527 weighted edges to represent the disease pheno-
typic similarities. We ﬁrst compared DMN with the networks representing genetic relationships among
diseases, and demonstrated that the phenotype clustering in DMN reﬂects common disease genetics.
Then we compared DMN with a widely-used disease phenotype network in previous gene discovery
studies, called mimMiner, which was extracted from the textual descriptions in Online Mendelian
Inheritance in Man (OMIM). We demonstrated that DMN contains different knowledge from the existing
phenotype data source. Finally, a case study on Marfan syndrome further proved that DMN contains use-
ful information and can provide leads to discover unknown disease causes. Integrating DMN in systems
approaches with mimMiner and other data offers the opportunities to predict novel disease genetics. We
made DMN publicly available at nlp/case.edu/public/data/DMN.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Linking complex human diseases to their genetic basis remains
a challenging task. For computational strategies to discover candi-
date disease genes, incorporating new data may lead to new dis-
coveries. Traditional methods prioritized genes for a disease if
the genes have similar functions with the known disease genes
[2,38,44,39,32,17,48]. Recent studies incorporate disease pheno-
type similarities in addition to the genomic data to increase the
ability of identifying new disease genes [19,23,43,46,47,16,35,37],
assuming that similar phenotypes and overlapping genetic causes
are correlated [5,29,15,2,9,10].
However, the disease phenotype networks used in current gene
prediction approaches remain largely incomplete. Most phenotype
databases were constructed through mining textual phenotype
descriptions [18,6]. For example, van Driel and the colleagues
extracted disease-phenotype associations from OMIM through text
mining, calculated the pairwise disease similarities, and storedthem in the database called mimMiner [42], which is one of the
most widely-used phenotype networks in recent disease gene dis-
covery methods [23,43,33,36,16]. Combining different phenotype
data has the potential to reduce the bias in each data source and
improve the network-based prediction models [26,30]. Therefore,
we explored new accurate and publicly accessible disease pheno-
type data in addition to the existing phenotype networks.
In this study, we created Disease Manifestation Network
(DMN), using the highly accurate and structured clinical manifes-
tation data from Uniﬁed Medical Language System (UMLS)
[24,4,25]. Clinical manifestation captures a major aspect of disease
phenotype and can predict disease causes [5]. For example, the
Stickler syndrome, Marshall syndrome and Otospondylomegaepi-
physeal dysplasia (OSMED) have highly similar manifestations
and also involve mutations in interacting collagen genes COL2A1,
COL11A2, and COL11A1, respectively [1]. The UMLS semantic net-
work currently uses 50,543 disease-manifestation semantic rela-
tionships to explicitly link 2,305 diseases to their clinical
manifestations. In this knowledge base, all disease and manifesta-
tion terms are formally represented by uniﬁed concepts and the
semantic relationships between concepts were collected frommul-
tiple different ontologies.
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gene relationships, but also contains different phenotypic knowl-
edge compared with mimMiner. We tested the hypothesis through
network comparative analysis between DMN, mimMiner [42], and
the two variants of human disease network (HDN) [12], which con-
nects diseases if they share genes. The correlation between DMN
and HDNs indicated that DMN reﬂects existing knowledge on
genetic relationships among diseases. The comparison between
DMN and mimMiner demonstrated that the two phenotype net-
works are largely complementary in nodes, edges and community
structures. The overall analysis suggests that combining DMN with
previous phenotype data sources, such as mimMiner, may poten-
tially improve the data-driven methods for biomedical applica-
tions, such as disease gene discovery and drug repositioning.2. Data and methods
Our study consists of the following steps (Fig. 1): (1) Con-
structed DMN using the disease-manifestation associations from
UMLS; (2) compare phenotypic relationships in DMN and genetic
relationships among diseases; (3) compared DMN with mimMiner
[42]; and (4) conducted a case study on the phenotypic relation-
ships of Marfan syndrome in DMN.
2.1. Construct DMN using disease-manifestation associations in UMLS
We ﬁrst extracted disease-manifestation relationships from the
UMLS ﬁle MRREL.RRF (2013 version). The ﬁle contains 647 differ-
ent kinds of semantic relationships between biomedical concepts.
We collected the concepts pairs linked by the ‘‘has manifestation’’
relationship, and obtained 50,543 disease-manifestation pairs. The
disease-manifestation relationships come from OMIM [14], Ultra-
sound Structured Attribute Reporting [3], and Minimal Standard
Digestive Endoscopy Terminology [40]. OMIM is the major contrib-
utor among these data sources.
The manifestation terms vary greatly in abundance. For exam-
ple, common manifestations such as ‘‘seizures’’ are associated withFig. 1. The four steps of netmany diseases, while rare manifestations such as ‘‘Amegakaryocy-
tic thrombocytopenia’’ are only associated with one disease. We
used the information content (1) to weight each manifestation
concept.
wc ¼ logðnc=NÞ ð1Þ
Variable wc is the weight of the manifestation concept c, nc is
the number of diseases associated with manifestation c, and N is
the total number of diseases. Then we modeled the manifestation
similarity between disease x and y by the cosine of their feature
vectors in (2), in which the feature vectors consist of manifesta-
tions xi and yi for disease x and y. The cosine similarity was used
before [19,42] to quantify phenotype overlaps.
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We constructed DMN as a weighted network with the manifesta-
tion similarities. The edges weights are in the range (0, 1].
2.2. Compare phenotypic relationships in DMN with genetic disease
associations
We conducted two experiments to evaluate whether the pheno-
typic relationships in DMN reﬂect genetic associations among dis-
eases. The ﬁrst experiment is to calculate the correlation between
the disease similarities in DMN and two quantiﬁed measures of
genetic associations. We ﬁrst ranked the edges (disease pairs) in
DMN by their weights (disease similarities) from large to small.
For top N disease pairs, we counted the percentage of disease pairs
that share associated genes in OMIM and the average number of
genes shared by the N disease pairs. Then we calculated the Pear-
son’s correlations between N and the genetic measures.
In the second experiment, we compared the network topologies
between DMN and two genetic disease networks. A well-studied
genetic disease network is HDN, in which diseases were connected
if they share associated genes in OMIM and edges were weightedwork analysis for DMN.
Fig. 2. Robustness of DMN with respect to the removal of random nodes and hub
nodes.
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network construction method of HDN, but used two different dis-
ease-gene association data: the updated data in OMIM (April,
2013) and GWAS catalog (August, 2013). We represented the dis-
ease terms in OMIM-based HDN and GWAS-based HDN with
2974 and 355 UMLS concept unique identiﬁers, respectively, to
enable the comparison with DMN. The two genetic disease net-
works both contains rich information of disease genetics [20,22],
but are largely different. The OMIM-based HDN mostly contains
Mendelian diseases with strong genetic causes; the GWAS-based
HDN mostly contains common complex diseases. The two net-
works only share 45 diseases.
We compared the edges and community structures between
DMN and the two HDNs. Network community structure reveals
the biological network properties and offered insights into cell
functions, protein interactions, and disease dynamics [8,31,34].
We applied a widely-used community detection algorithm [28]
and calculated the two-way similarities between community
groups:
SDMN!HDN ¼ jX \ Y j=jXj ð3Þ
SHDN!DMN ¼ jX \ Y j=jYj ð4Þ
j X j and j Y j are the number of disease pairs that appear in the
same community in DMN and HDN, respectively. j X \ Y j is the
count of disease pairs that were grouped into one community in
both networks.
We tested the signiﬁcance of edge and community similarities
between DMN and HDNs by creating a background distribution
of similarities expected at random. We kept the number and size
of communities in DMN, and randomly swapped the assignments
of disease nodes into each community. Then we linked nodes
inside a community with probability Pin, and those across commu-
nities with probability Pout . The Pin and Pout were estimated from
the edge density within and between communities in DMN,
respectively. We repeated 100 times of randomizing DMN, and
compared each random network to HDNs to create the background
signals. Finally, we compared the observed similarities with the
background signals using Wilcoxon signed-rank test.
2.3. Compare DMN with the widely-used disease phenotype network
mimMiner
DMN and mimMiner both contain phenotypic knowledge based
on clinical observations. Here, we compared DMN with mimMiner
to demonstrate that the two phenotype networks contain different
knowledge, so that combining them in applications, such as dis-
ease gene discovery and drug repositioning, may potentially lead
to improved performance. We ﬁrst mapped the 5080 diseases in
mimMiner from OMIM identiﬁers to UMLS concept unique identi-
ﬁers to allow the comparison. Since text mining introduced false
positive disease-phenotype relationships, we needed to tradeoff
between the data coverage and accuracy in mimMiner. Based on
previous analysis [42], we chose to connect two disease nodes if
their similarities are above 0.3. The network of mimMiner contains
4,391 disease nodes after these processes. We then compared the
node, edges and community structures between DMN with
mimMiner.
2.4. Case study on Marfan syndrome
Marfan syndrome is a common inherited disorder of the connec-
tive tissue, occurring once in every 10,000 to 20,000 individuals
[45]. About 75% of patients with Marfan syndrome have mutations
in the FBN1 gene, which encodes brillin-1, a protein that provides
strength and ﬂexibility to connective tissue. Despite this well-deﬁned mutation, gene FBN1 cannot always predict the wide vari-
ety of phenotypes in patients, and other unknown genetic factors
that account for the diversiﬁed phenotypes of Marfan syndrome
may exist. Here, we conducted a case study on Marfan syndrome
and its phenotype relationships in DMN. We compared the corre-
sponding subnetworks in DMN, mimMiner and HDN to show that
the DMN contains different phenotypic knowledge and has the
potential in deepening the understanding of MS pathogenesis.3. Results
3.1. DMN network properties
DMN contains 2305 nodes and 373,527 edges. The network has
a long-tail degree distribution and is robust to random removal of
nodes. Removing the nodes with large degrees can quickly break
down the network into small components (Fig. 2). Table 1 lists
the network properties of DMN. To understand DMN better, we
also showed the properties of three other disease networks, includ-
ing OMIM-based HDN, GWAS-based HDN and mimMiner. DMN is
denser than mimMiner, but the nodes tend to cluster into disjoint
components. Both the phenotype networks are evidently different
from the genetic networks: DMN andmimMiner are denser (higher
network density), less cliquish (lower clustering coefﬁcients) and
more connective (less connected components) than HDNs. Fig. 3
shows example subnetworks from DMN, mimMiner, and HDNs
containing randomly sampled nodes. In contrast to the densely-
connected subnetworks of DMN and mimMiner, OMIM-based
HDN mostly contains small components such as triangles and
chains. GWAS-based HDN contains complex diseases, which are
often associated with multiple genes, thus its edge density is
higher than OMIM-based HDN, but still lower than DMN.
The differences in global structures between phenotype and
genetic disease networks indicate that we may have not fully dis-
covered the genes accounting for the observed phenotypic connec-
tions. Systematic studying the disease phenotype networks offers a
chance to detect new disease genes, particularly for the disease
whose genetic basis is completely unknown. Note that non-genetic
factors, such as common environments and life styles, may also
contribute to the overlapping phenotypes. To evaluated the poten-
tial of phenotype networks to predict disease genes, we show the
correlation between phenotypic and genetic relationships in the
next section.
3.2. DMN partially correlates with the genetic disease networks
In the ﬁrst experiment, we found that the manifestation simi-
larities in DMN have correlations with quantiﬁed measures of dis-
ease genetic associations. Fig. 4 (left) shows that the disease pairs
with larger manifestation similarities (higher ranks) are more
Table 1
Global properties of DMN and the other disease networks, including HDNs (genetic disease networks) and mimMiner (widely-used phenotype network) based on OMIM text
mining. The last three columns represent average shortest path, average cluster coefﬁcient, and connected component, respectively.
Disease network Number of nodes Network density Network diameter Avg. shortest path Avg. clu. coeff. Conn. comp.
DMN 2305 0.14 6 2.042 0.649 6
HDN(OMIM) 2974 0.001 9 2.341 0.74 797
HDN(GWAS) 355 0.054 5 2.505 0.702 17
MimMiner 4391 0.044 7 2.445 0.421 1
(a) (b)
(c) (d)
Fig. 3. Randomly selected subgraphs of (a) DMN, (b) mimMiner, (c) OMIM-based HDN and (d) GWAS-based HDN. Only part of the node labels are shown in the ﬁgure due to
space limit. In contrast to DMN and mimMiner, the sub-graphs in HDNs are less connective and cliquish.
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of manifestation similarities and the probabilities of sharing gene
is 0.603 (p E8). Also, Fig. 4 (right) shows that diseases with
larger manifestation similarities tend to share more genes. The
Pearson’s correlation between the ranks of manifestation similari-
ties and average number of shared genes is 0.647 (p E8).
We found that only a small percentage of disease pairs share
associated genes despite the signiﬁcant correlations between phe-
notype similarities and genetic associations. For example, among
the top ﬁve disease pairs with highest phenotype similarities, only
one pair shared associated genes. This observation indicates thatthe overlapping manifestations may result from unknown genes,
shared pathways, protein complexes, or common environment.
Discovering unknown genetic factors responsible for overlapping
phenotypes among diseases is one of the goals of studying the dis-
ease phenotype networks.
In the second experiment, we compared the edges and commu-
nity structures of DMN with the genetic disease networks. Table 2
shows that the number of common edges between DMN and HDNs
is signiﬁcant higher than the random distribution. We found that
mimMiner also contains 520 common edges with OMIM-based
HDNand 14withGWAS-basedHDN.However, DMNandmimMiner
Fig. 4. Correlation between manifestation similarities and genetic associations. Left: Correlation between proportion of genetically associated disease pairs (x-axis) and the
phenotype similarity ranks (y-axis) in DMN. Right: Correlation between the average numbers of genes shared by disease pairs (x-axis) and the phenotype ranks (y-axis) in
DMN. Diseases with larger phenotype similarity in DMN tend have stronger genetic association.
Table 2
Compare the edge overlaps N between DMN and the genetic disease networks.
Network B0 represents the randomized graph that preserves the properties of
Network B. Column NðA;B0 Þ represents the average number of edge overlap comparing
network A and the randomized networks.
Network A Network B NðA;BÞ NðA;B0 Þ P-value
HDN(OMIM) DMN 278 65.4  E8
HDN(GWAS) DMN 6 2.93  E8
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edge overlaps between DMN and OMIM-based HDN do not appear
in mimMiner, and 5 of 6 edge overlaps between DMN and
GWAS-based HDN do not appear in mimMiner.
Table 3 lists the community structure similarities between
DMN and HDNs. If two diseases are grouped together in OMIM-
based HDN, they have over 60% chances to stay in one community
in DMN. On the other hand, diseases in one community in DMN
have 0.6% chance of being grouped together in OMIM-based
HDN. The absolute values of community structure similarities
may be biased: OMIM-based HDN mostly contains small size
clusters, and the probability of two diseases share one cluster is
naturally low. However, statistical test shows that the similarities
in community partitions between DMN and HDN are signiﬁcantly
higher than the random distribution, indicating that the observed
similarities reﬂect intrinsic correlations between the biological
networks. The community structure correlation between DMN
and GWAS-based HDN is also signiﬁcant compared with random
signals.
In summary, DMN is partially correlated with the genetic dis-
ease networks in both edges and community structures. On the
one hand, the phenotype relationships among diseases in DMN
reﬂects shared genetic mechanisms. On the other hand, manyTable 3
Compare the community structures between DMN and the genetic disease networks.
SA!B and SB!A represent the two-way the similarity in community partitions between
network A and B.
Network A Network B SA!B SA!B0 P-value SB!A SB!A0 P-value
HDN(OMIM) DMN 0.655 0.281  E8 0.006 0.002  E8
HDN(GWAS) DMN 0.611 0.279  E8 0.297 0.156  E8disease-associated genes and pathways may have not been discov-
ered yet. In addition, comparative analysis to HDNs also show that
DMN and mimMiner contain different knowledge. The phenotype
relationships in DMN have the potential to provide leads for dis-
covering new disease genetics.3.3. DMN contains knowledge different from mimMiner
We compared DMN with the widely-used phenotype network
mimMiner to show their differences. Table 4 summarizes their dif-
ferences in nodes, edges, and community structures. Though DMN
shares 75% of the nodes with mimMiner, 295,975 edges (79.2%) are
unique and do not appear in mimMiner. Examples of the unique
edges are schizophrenia–myopia, autism–tuberous sclerosis, and
familial mediterranean fever–alport syndrome. We extracted all
unique disease pairs in DMN and made the data publicly accessi-
ble. In addition, the community structures of DMN and mimMiner
are partly correlated. The community similarities in the two direc-
tions are comparable and both moderate, showing that we cannot
completely predict the phenotype clusters in one network based
on the other. Therefore, the knowledge captured in DMN and mim-
Miner is complementary. Integrating these two networks is valu-
able for better prediction of candidate disease genes.3.4. Case study of Marfan syndrome
We have demonstrated the difference between DMN and mim-
Miner through network comparison. In this section, we conducted
a case study on Marfan syndrome (Ms) to further compare disease
relationships in DMN and mimMiner. The direct neighbors of MS in
DMN (665 nodes) and mimMiner (363 nodes) have overlaps (241
common neighbors), but are largely different. Fig. 5 shows the
top twenty MS neighbors with the highest weights in DMN, mim-
Miner and OMIM-based HDN (GWAS-based HDN does not contain
MS, therefore is not shown). The difference shows that the pheno-
type networks may contain new leads to discover the unknownTable 4
Compare DMN with mimMiner in nodes, edges and community structures.
Network A Network B Unique node Unique edge WA!B WB!A
mimMiner DMN 582 (25.2%) 295,975 (79.2%) 0.392 0.533
(a) (c)
(b)
Fig. 5. Top 20 nodes directly connected to Marfan syndrome with the highest weights in (a) DMN, (b) mimMiner, and (c) HDN. The common nodes among the three sub-
networks are highlighted. The thickness of edges represents the weights.
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(Fig. 5(b)) share six of the twenty nodes. The edges in the DMN
subgraph vary greatly in weights, while those in the mimMiner
subgraph have almost uniform weights. Both the phenotype net-
works contain disease relationships that cannot be found in the
other, hence are able to complement each other. For example,
Lujan-Fryns syndrome (LFS) is among the top neighbors of MS in
DMN, but is not connected to MS in mimMiner. Many literatures
support the phenotype similarities between LFS and MS, such as
tall stature, long limbs, and heart problems [11,41,27,13]. Inspired
by these common phenotype features, a few studies looked for new
genetic origins of MS and LFS [21,7].
We manually traced the data sources to explain the different
connections between LFS and MS in the two phenotype networks.
For DMN, we extracted disease-manifestation associations from
UMLS ontologies and found seven common manifestations
between LFS and MS, such as ‘‘Contracture of joint,’’ ‘‘Congenital
funnel chest,’’ and ‘‘Aneurysm of ascending aorta.’’ For mimMiner,
we manually curated both full text and clinical synopsis ﬁelds from
OMIM disease records for both diseases, but only found three out
of the seven common manifestations in UMLS shared by the two
diseases. In addition, and text mining approaches introduced false
signals when extracting disease-phenotype associations. As a
result, the LFS-MS connection has a weight below the threshold
in mimMiner.
One disadvantage of mimMiner is that we need to control the
false positive disease-phenotype associations introduced by text
mining. Practical applications, such as candidate disease gene pre-
diction tasks, chose stringent threshold for disease similarities,
which is often higher than 0.3 [19,23]. However, one threshold
hardly ﬁts all diseases. Directly removing disease pairs with smallsimilarities may cause the miss of true disease connections such as
LFS-MS. The disease-phenotype associations in UMLS were obser-
vations rather than the result of text mining, hence do not require
the users to control the false positive signals. Therefore, combining
DMN with mimMiner may improve the quality of disease pheno-
type network.4. Discussion
We have constructed a phenotype network using the clinical
manifestation data from the biomedical ontologies, and demon-
strated the correlation between the manifestations based pheno-
type relationships and genetic associations among diseases. We
have also compared DMN with another phenotype network that
has been widely-used in candidate gene selection. Results show
that the two phenotype networks are largely complementary.
Our work has a few limitations and can be improved in future
studies. First, the manifestation data in UMLS is highly accurate
but is limited in size. Though we have used 50,543 disease-mani-
festation pairs to construct DMN, the number of nodes in DMN is
smaller than that in mimMiner. To increase the coverage of dis-
eases, we need to integrate DMN and mimMiner and obtain a more
complete phenotype network. In addition, many nodes in DMN are
syndromes and rare diseases. Phenotype data obtained from other
sources, such as literature, contains information of more common
diseases and can greatly complement DMN. Currently, we are
developing approaches to integrate heterogeneous phenotype net-
works, including DMN, mimMiner, and the network constructed
from the disease-manifestation relationships based on literature
mining [49].
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ences in the community structures between DMN and HDNs. One
possible reason is that many disease associated genes may have
not been discovered yet and the community structure of the genetic
networksmay largely bias towards known knowledge. In the future,
we plan to discover new disease-gene associations by analyzing the
observed phenotype similarities. Also, since similar manifestations
between diseasesmay be caused by common functional modules or
pathways, we will integrate gene functional relationships with the
phenotype network in detecting new disease mechanisms.
Third, phenotypic data is high-dimensional, containing not only
manifestations, but also other aspects on levels from genes, cells to
organisms. Though our network uses highly accurate manifesta-
tion data, it can only reﬂect one aspect of the phenotype associa-
tions. In the future, we will integrate the DMN with multiple
other kind of phenotype data, and incorporate the comprehensive
phenotype network in disease gene discovering methods.
Finally, the scope of this study is to demonstrate the potential of
DMN to predict unknown disease mechanisms. Our analysis
showed the signiﬁcant positive correlation between manifestation
similarities and genetic overlaps among diseases through compar-
ative analysis. To use DMN in discovering new disease mecha-
nisms, however, we still need to develop systems approaches and
exploit other network characteristics, such as network local struc-
tures, which are not discussed in this study.
5. Conclusions
Systems approaches in studying disease phenotype networks
have great potential in discovering unknown disease mechanisms.
Currently, disease phenotype networks remain largely incomplete.
Clinical manifestation is an important aspect of the phenotype data.
In this study, we built a disease phenotype network, DMN, using the
high quality disease-manifestation semantic relationship data from
ontologies in the UMLS. Phenotype-genotype correlation analysis
based on network comparison have demonstrated that the pheno-
type relationships in DMN reﬂects overlapping genetic mechanisms
of diseases, but also contains new leads to discover genetic disease
causes. Also, we have shown that DMN and a widely-used pheno-
type network are complementary. With the integration of pheno-
type data from other sources, our network could strengthen
current candidate disease-gene selection methods.
Author’s contributions
RX conceived the study. YC and RX designed the experiment. YC
performed the experiment and wrote the manuscript. All authors
have participated study discussion and manuscript preparation.
Acknowledgments
YC, GZ and RX are funded by Case Western Reserve University/
Cleveland Clinic CTSA Grant (UL1TR000439). XZ are partially
supported by US National Science Foundation IIS-1162374 and
IIS-1218036. We would like to thank our funding and the
reviewers for their invaluable comments and suggestions.
References
[1] Annunen S, Körkkö J, Czarny M, Warman ML, Brunner HG, Kääriäinen H, et al.
Splicing mutations of 54-bp exons in the col11a1 gene cause marshall
syndrome, but other mutations cause overlapping marshall/stickler
phenotypes. Am J Human Genet 1999;65(4):974–83.
[2] Barabási AL, Gulbahce N, Loscalzo J. Network medicine: a network-based
approach to human disease. Nat Rev Genet 2011;12(1):56–68.
[3] Bell DS, Greenes R, Doubilet P. Form-based clinical input from a structured
vocabulary: initial application in ultrasound reporting. In: Proceedings of theannual symposium on computer application in medical care. American
Medical Informatics Association; 1992. p. 789.
[4] Bodenreider O. The uniﬁed medical language system (umls): integrating
biomedical terminology. Nucl Acids Res 2004;32(Suppl. 1):D267–70.
[5] Brunner HG, van Driel MA. From syndrome families to functional genomics.
Nat Rev Genet 2004;5(7):545–51.
[6] Butte AJ, Kohane IS. Creation and implications of a phenome-genome network.
Nat Biotechnol 2006;24(1):55–62.
[7] Callier P, Aral B, Hanna N, Lambert S, Dindy H, Ragon C, et al. Systematic
molecular and cytogenetic screening of 100 patients with marfanoid
syndromes and intellectual disability. Clin Genet 2013.
[8] Caretta-Cartozo C, De Los Rios P, Piazza F, Liò P. Bottleneck genes and
community structure in the cell cycle network of s. pombe. PLoS Comput Biol
2007;3(6):e103.
[9] Fang H, Gough J. A disease-drug-phenotype matrix inferred by walking on a
functional domain network. Mol BioSyst 2013;9(7):1686–96.
[10] Fang H, Gough J. A domain-centric solution to functional genomics via dcgo
predictor. BMC Bioinform 2013;14(Suppl. 3):S9.
[11] Fryns J-P, Buttiens M, Opitz JM, Reynolds JF. X-linked mental retardation with
marfanoid habitus. Am J Med Genet 1987;28(2):267–74.
[12] Goh K-I, Cusick ME, Valle D, Childs B, Vidal M, Barabási A-L. The human disease
network. Proc Natl Acad Sci 2007;104(21):8685–90.
[13] Grahame R, Hakim AJ. Arachnodactyly-a key to diagnosing heritable disorders
of connective tissue. Nat Rev Rheumatol 2013;9(6):358–64.
[14] Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online mendelian
inheritance in man (omim), a knowledgebase of human genes and genetic
disorders. Nucl Acids Res 2005;33(Suppl. 1):D514–7.
[15] Houle D, Govindaraju DR, Omholt S. Phenomics: the next challenge. Nat Rev
Genet 2010;11(12):855–66.
[16] Hwang T, Atluri G, Xie M, Dey S, Hong C, Kumar V, et al. Co-clustering
phenome–genome for phenotype classiﬁcation and disease gene discovery.
Nucl Acids Res 2012;40(19). e146-e146.
[17] Köhler S, Bauer S, Horn D, Robinson PN. Walking the interactome for
prioritization of candidate disease genes. Am J Human Genet
2008;82(4):949–58.
[18] Korbel JO, Doerks T, Jensen LJ, Perez-Iratxeta C, Kaczanowski S, Hooper SD,
et al. Systematic association of genes to phenotypes by genome and literature
mining. PLoS Biol 2005;3(5):e134.
[19] Lage K, Karlberg EO, Størling ZM, Olason PI, Pedersen AG, Rigina O, et al. A
human phenome-interactome network of protein complexes implicated in
genetic disorders. Nat Biotechnol 2007;25(3):309–16.
[20] Lee Y, Li H, Li J, Rebman E, Achour I, Regan KE, et al. Network models of
genome-wide association studies uncover the topological centrality of protein
interactions in complex diseases. J Am Med Inform Assoc 2013;20(4):619–29.
[21] Lerma-Carrillo I, Molina JD, Cuevas-Duran T, Julve-Correcher C, Espejo-
Saavedra JM, Andrade-Rosa C, et al. Psychopathology in the lujan–fryns
syndrome: report of two patients and review. Am J Med Genet Part A
2006;140(24):2807–11.
[22] Li H, Lee Y, Chen JL, Rebman E, Li J, Lussier YA. Complex-disease networks of
trait-associated single-nucleotide polymorphisms (snps) unveiled by
information theory. J Am Med Inform Assoc 2012;19(2):295–305.
[23] Li Y, Patra JC. Genome-wide inferring gene–phenotype relationship by walking
on the heterogeneous network. Bioinformatics 2010;26(9):1219–24.
[24] Lindberg DA, Humphreys BL, McCray AT. The uniﬁed medical language system.
Methods Inform Med 1993;32(4):281–91.
[25] McCray AT. An upper-level ontology for the biomedical domain. Compar Funct
Genom 2003;4(1):80–4.
[26] Mestres J, Gregori-Puigjané E, Valverde S, Sole RV. Data completeness-the
achilles heel of drug-target networks. Nat Biotechnol 2008;26(9):983–4.
[27] Murphy-Ryan M, Psychogios A, Lindor NM. Hereditary disorders of connective
tissue: a guide to the emerging differential diagnosis. Genet Med
2010;12(6):344–54.
[28] Newman ME, Girvan M. Finding and evaluating community structure in
networks. Phys Rev E 2004;69(2):026113.
[29] Oti M, Huynen MA, Brunner HG. Phenome connections. Trends Genet
2008;24(3):103–6.
[30] Oti M, Huynen MA, Brunner HG. The biological coherence of human phenome
databases. Am J Human Genet 2009;85(6):801–8.
[31] Palla G, Derényi I, Farkas I, Vicsek T. Uncovering the overlapping community
structure of complex networks in nature and society. Nature
2005;435(7043):814–8.
[32] Piro RM, Di Cunto F. Computational approaches to disease-gene prediction:
rationale, classiﬁcation and successes. FEBS J 2012;279(5):678–96.
[33] Piro RM, Molineris I, Di Cunto F, Eils R, König R. Disease-gene discovery by
integration of 3d gene expression and transcription factor binding afﬁnities.
Bioinformatics 2013;29(4):468–75.
[34] Salathé M, Jones JH. Dynamics and control of diseases in networks with
community structure. PLoS Comput Biol 2010;6(4):e1000736.
[35] Sifrim A, Popovic D, Tranchevent L-C, Ardeshirdavani A, Sakai R, Konings P,
et al. Extasy: variant prioritization by genomic data fusion. Nat Methods
2013;10(11):1083–4.
[36] Singh-Blom UM, Natarajan N, Tewari A, Woods JO, Dhillon IS, Marcotte EM.
Prediction and validation of gene-disease associations using methods inspired
by social network analyses. PloS One 2013;8(5):e58977.
[37] Singleton MV, Guthery SL, Voelkerding KV, Chen K, Kennedy B, Margraf RL,
et al. Phevor combines multiple biomedical ontologies for accurate
120 Y. Chen et al. / Journal of Biomedical Informatics 53 (2015) 113–120identiﬁcation of disease-causing alleles in single individuals and small nuclear
families. Am J Human Genet 2014;94(4):599–610.
[38] Tifﬁn N, Andrade-Navarro MA, Perez-Iratxeta C. Linking genes to diseases: it’s
all in the data. Genome Med 2009;1(8):77.
[39] Tranchevent L-C, Capdevila FB, Nitsch D, De Moor B, De Causmaecker P,
Moreau Y. A guide to web tools to prioritize candidate genes. Brief Bioinform
2011;12(1):22–32.
[40] Tringali M, Hole WT, Srinivasan S. Integration of a standard gastrointestinal
endoscopy terminology in the umls metathesaurus. In: Proceedings of the
AMIA symposium. American Medical Informatics Association; 2002. p. 801.
[41] Van Buggenhout G, JP F. Lujan-fryns syndrome (mental retardation, x-linked,
marfanoid habitus). Orphanet J Rare Dis 2006;1(26):325.
[42] van Driel MA, Bruggeman J, Vriend G, Brunner HG, Leunissen JA. A text-mining
analysis of the human phenome. Eur J Human Genet 2006;14(5):535–42.
[43] Vanunu O, Magger O, Ruppin E, Shlomi T, Sharan R. Associating genes and
protein complexes with disease via network propagation. PLoS Comput Biol
2010;6(1):e1000641.[44] Wang X, Gulbahce N, Yu H. Network-based methods for human disease gene
prediction. Brief Funct Genom 2011;10(5):280–93.
[45] Webb GD, Smallhorn JF, Therrien J. Congenital heart disease. In: Bonow RO,
Man DL, Zipes DP, editors. Heart disease: a textbook of cardiovascular
medicine, 9th ed., vol. 2. Saunders Elsevier; 2011. p. 53–76.
[46] Wu X, Jiang R, Zhang MQ, Li S. Network-based global inference of human
disease genes. Mol Syst Biol 2008;4(1).
[47] Wu X, Liu Q, Jiang R. Align human interactome with phenome to identify
causative genes and networks underlying disease families. Bioinformatics
2009;25(1):98–104.
[48] Xu J, Li Y. Discovering disease-genes by topological features in human protein–
protein interaction network. Bioinformatics 2006;22(22):2800–5.
[49] Xu R, Li L, Wang Q. Towards building a disease-phenotype knowledge base:
extracting disease-manifestation relationship from literature. Bioinformatics
2013;29(17):2186–94.
